Real-world performance analysis of a universal computational reasoning model for precision oncology in lung cancer

Tumors harbor multiple genetic alterations, yet treatment decisions are commonly based on single biomarkers, leading to underutilization of genomic information by comprehensive molecular tests, uncertainty in clinical practice, and frequent treatment failures. Although molecular tumor boards can assist personalized treatments, this process is not scalable or standardized, resulting in highly discordant recommendations. Validated digital solutions for personalized decision support are highly needed. The Digital Drug Assignment (DDA) system is a computational reasoning model that scores treatment options based on the full tumor genomic data. We retrospectively analyzed data of 111 lung cancer patients and found that high-score MTAs (1000≦DDA score) provided significant clinical benefit over other treatments, in terms of ORR, PFS, and OS. These results demonstrate that the DDA system is predictive of relative benefit of the various agents used in lung cancer care. Digital drug assignment can potentially address challenges with complex molecular profiles in routine clinical settings.

Authors

Institutions

Publication Details

Journal
npj Precision Oncology
Published
2025-05-30
DOI
https://doi.org/10.1038/s41698-025-00943-4
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world performance analysis of a universal computational reasoning model for precision oncology in lung cancer

Dóra Lakatos, Júlia Déri, Richard B. Schwab, István Vályi‐Nagy et al.
1 links
npj Precision Oncology
Radiomics and Machine Learning in Medical Imaging
article

Real-world performance analysis of a universal computational reasoning model for precision oncology in lung cancer

Dóra Lakatos, Júlia Déri, Richard B. Schwab, István Vályi‐Nagy, Ákos Boldizsár, Gábor Kalmár, Réka Szalkai-Dénes, Dóra Mathiász, Róbert Dóczi, István Peták, Maud Kamal, László Urbán, Dóra Kormos, Christophe Le Tourneau, Viktor Kardos, Barbara Vodicska, Anna Dirner, Christian Diego Rolfo, Edit Várkondi, Dóra Tihanyi, Gábor Pajkos, Arkadiusz Z. Dudek, Márton Bolyácz, Mária Kocsis-Steinbach, Ákos Takács
article en

Abstract

Tumors harbor multiple genetic alterations, yet treatment decisions are commonly based on single biomarkers, leading to underutilization of genomic information by comprehensive molecular tests, uncertainty in clinical practice, and frequent treatment failures. Although molecular tumor boards can assist personalized treatments, this process is not scalable or standardized, resulting in highly discordant recommendations. Validated digital solutions for personalized decision support are highly needed. The Digital Drug Assignment (DDA) system is a computational reasoning model that scores treatment options based on the full tumor genomic data. We retrospectively analyzed data of 111 lung cancer patients and found that high-score MTAs (1000≦DDA score) provided significant clinical benefit over other treatments, in terms of ORR, PFS, and OS. These results demonstrate that the DDA system is predictive of relative benefit of the various agents used in lung cancer care. Digital drug assignment can potentially address challenges with complex molecular profiles in routine clinical settings.

npj Precision OncologyVol. 9(1)
Semmelweis University (HU), Mayo Clinic (US), University of Matanzas (CU), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), University of Illinois Chicago (US), National Institute of Oncology (HU), International Drug Development (FR), Genomic Health (United States) (US), Széchenyi István University (HU)
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Good health and well-being
Openalex Percentile: Top 81%
Radiomics and Machine Learning in Medical Imaging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.